Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Kezar Life Sciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 77 | 107 | +30 |
| Shares | 28.1M | 40.4M | +12.3M (+43.9%) |
| Value | $242.7M | $674.1M | +$431.4M (+177.7%) |
New holders (39)
Institutions that held Kezar Life Sciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (9)
Institutions that held Kezar Life Sciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| OrbiMed Advisors LLC | 1,150,000 | $9.94M |
| AJU IB Investment Co., Ltd. | 128,916 | $1.11M |
| Grantham, Mayo, Van Otterloo & Co. LLC | 70,319 | $608.0K |
| Martingale Asset Management L P | 26,119 | $226.0K |
| Prudential Financial Inc | 12,566 | $109.0K |
| Meeder Asset Management Inc | 6,009 | $53.0K |
| Penserra Capital Management LLC | 1,100 | $9.00K |
| Group One Trading, L.P. | 604 | $5.00K |
| Meridian Wealth Partners, LLC | 233 | $2.00K |